Transactions

Katzenell Dimant /

KD represents HIL in series C financing

It has just been announced that Belgian company IBA (Ion Beam Applications S.A.), a provider of proton therapy solutions for the treatment of cancer, is leading a round of capital investment in HIL Applied Medical, Ltd. (HIL), a private Israeli developer of laser-based proton therapy systems.

Read more
Katzenell Dimant /

KD represents Vonetize in first IPO of 2016

Congratulations to our client Vonetize for a successful IPO! We are also proud of our own team for having played a crucial role in the first Tel Aviv Stock Exchange IPO for 2016.

Read more
Katzenell Dimant /

KD represents SteadyMed in $32 Million Private Placement

Our client SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan …

Read more
Katzenell Dimant /

KD Represents Arilou in NNG exit

It has just been announced that iGO developer NNG has acquired our client – automotive cyber startup Arilou Technologies. Arilou’s technology is designed to prevent a remote takeover of the car’s computerized systems (multimedia and locking systems, for example) that could enable a burglar to open the car’s locks, turn off the motor, and even disconnect the brakes.

Read more
Katzenell Dimant /

KD represents HIL in acquisition of US-based Nanolabz Inc.

It has just been announced that our client HIL Applied Medical Ltd. has acquired US-based Nanolabz Inc. en route to developing …

Read more
Katzenell Dimant /

KD represents eyeSight on $20M financing deal

We are very proud of our client, eyeSight Mobile Technologies, for closing a $20,000,000 strategic transaction with Kuang-Chi Science, and …

Read more
Katzenell Dimant /

KD represents Multiphy Ltd. in $8,500,000 financing

Katzenell Dimant represents Multiphy Ltd. in an $8.5 million financing round led by strategic partners and VCs. Read the press …

Read more
Katzenell Dimant /

KD represents Kitov Pharmaceuticals in publishing Prospectus

Katzenell Dimant represents Kitov Pharmaceuticals Holdings Ltd. in publishing a prospectus for public issuance of rights to purchase its securities and registration …

Read more
Katzenell Dimant /

KD represents seller of Marmar Media shares to XLMedia for US$7M

Katzenell Dimant represents the seller of Marmar Media Ltd. shares in a transaction for sale of a majority of the shares …

Read more